Pain Neuroscience Education and Physical Exercise Program in Chronic Back Pain

Pain Neuroscience Education and Physical Exercise Program in Patients With Chronic Back Pain. Intervention From Primary Care Physiotherapy Units

This study evaluates the effects of a pain neuroscience education (PNE) and physical exercise (PE) program in patients with chronic back pain. Half of participants receive PNE and PE program supervised by a physiotherapist and the other half receive usual physiotherapy care supported by physiotherapy protocols in primary care.

Study Overview

Detailed Description

Justification: Chronic musculoskeletal pain (CMP) affects more than 20% of the population, its prevalence is increasing, generating suffering and high health expenditure. The current knowledge of neurophysiology of pain shows that the painful experience in CMP is not necessarily associated with peripheral tissue damage and is due more to an alteration of central mechanisms of pain processing and to the dysfunction of endogenous pain inhibitory mechanisms. Physical exercise (PE) has been shown to be effective in CMP. Pain neuroscience education (PNE) improves the levels of pain catastrophism, Kinesiophobia, quality of life, disability and also modifies maladaptive cognitions that favour a painful response.

Objectives: To evaluate the efficacy of a PNE and PE in patients with chronic back pain (CBP). Changes in pain intensity, pain thresholds, Catastrophism, kinesiophobia, disability, central sensitization and quality of are measured.

Material and methods: Multicenter randomized clinical trial (RCT) with 170 patients. Intervention group receive 6 sessions of PNE and a 6 weeks PE program (18 sessions) aimed at improving functional capacity, neurogenesis and cerebral plasticity. Control group receive usual physiotherapy treatment (supported by the current protocols in Primary Care in the Health System of Castilla y León). The outcome variables are measured by Visual Analog Scale (EVA), Pressure Pain Threshold (PPT), Kinesiophobia Tampa Scale (TKS-11), Central Sensitization Questionnaire (CSC), Pain Catastrophism Questionnaire (CCD), disability (Roland-Morris), Quality of life (SF-36) and satisfaction (CSQ-8). An initial assessment, post-intervention (week 10), at six months and at year is performed. Patients Evaluator and Outcomes Assessor are masked.

Applicability of results: The proposed intervention is simple and reproducible. It can be performed in the Primary Care Physiotherapy Units. It requires few resources, and it can produce changes in pain intensity, functionality and quality of life of patients with CBP

Study Type

Interventional

Enrollment (Anticipated)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Valladolid, Spain, 47011
        • Recruiting
        • Unidad de estrategias de Afrontamiento Activo para el dolor. Sacyl
        • Contact:
        • Sub-Investigator:
          • Federico Montero Cuadrado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nonspecific back pain of at least 6 months.
  • Accept to participate in the study and sign the informed consent.

Exclusion Criteria:

  • Oncological pain.
  • Spine fracture or surgical intervention in last year.
  • Neurological cognitive alteration that prevents understanding the contents of PNE program (In case of doubt, assesment with Minimental test)
  • Motor control alteration that prevents the execution of the planned PE program (Minimum requirement: execution in normal time of the Timed Up and Go test)
  • Pregnancy.
  • Bladder or bowel incontinence.
  • Saddle anesthesia.
  • Patients presenting other clinical conditions that may aggravate chronic spinal pain (chronic fatigue syndrome, fibromyalgia and complex regional pain syndrome).
  • Patients with associated pathologies that make it impossible to perform physical exercise program.
  • Patients under treatment with alternative therapies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PNE and PE program
Pain neuroscience education (Health education) and Physical exercise program.
6 pain neuroscience education sessions (10 hours) and delivery of printed reinforcement material.
Group physical exercise program (18 sessions; 3 sessions/week) leaded by a physiotherapist. It includes exercises to improve strength, coordination, balance and aerobic capacity. Work with double tasks, recreational activities to overcome kinesiophobia and activities to do at home are used in the program.
ACTIVE_COMPARATOR: Usual care in Primary Care Physiotherapy
Usual care in Primary Care Physiotherapy Units

Treatment supported by the protocol of primary care of physiotherapy in the health service of Castilla y León that was in force at the time of the intervention.

Patients receive 15 sessions of analgesic electrotherapy, thermotherapy and standardized physical exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health-related Quality of Life at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) V2. Spanish version. The SF-36 is a 36-item scale constructed to survey health status and quality of life. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary. Each scale is directly transformed into a 0-100 scale. Higher scores indicate better overall quality of life.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain assessment at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Visual analog scale (VAS) scale. The VAS is a 100 mm long horizontal line ranging from '0: no pain at all' on one end to '100: worst pain imaginable' on the other end. Participants mark a point along the line that best represents the pain they are experiencing at that moment. A higher score indicates a higher level of pain.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Pressure pain threshold.
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Pressure pain threshold (PPT). A digital pressure algometer is used at four standardized points to measure the pressure pain thresholds. Higher values represent a better tolerance to pressure pain.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Change in Pain Catastrophism at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Pain catastrophizing scale (PCS). Spanish version. PCS is a short 13-item measure which evaluates the pain-related catastrophizing behaviours and cognitions of individuals. Score range from 0 - 52. A higher score indicates a higher level of catastrophism.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Change in Kinesiophobia at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Tampa Scale of Kinesiophobia (TSK-11). Spanish version. TSK-11 is a self-report measure that contains 11 questions designed to assess a client's fear of movement and re-injury. Score range from 11 - 44. A higher score indicates a higher level of Kinesiophobia.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Change in Disability at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Roland-Morris Disability Questionnaire (RMDQ). Spanish version. It is a self-administered disability questionnaire consisting of 24 questions that are specifically related to physical functions that may be affected by back pain. Score range from 0 - 24. A higher score indicates a higher level of Disability.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Change in Central sensitization levels at different time points
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Central sensitization Inventory (CSI). Spanish version. Self-report instrument to detect the presence of central sensitization. It is a 25-item questionnaire that records the frequency of each symptom on a Likert scale from 0 (never) to 4 (always), resulting in a possible total score of 100. Higher scores are associated with higher levels of central sensitization.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Change in Drugs consumption
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Record of consumption by types of drugs. Consumption is evaluated through a survey. The results are expressed in weekly doses per drug type.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up
Satisfaction survey. Satisfaction with the treatment
Time Frame: at 10 weeks
Client Satisfaction Questionnaire (CSQ-8). Spanish version. It is is a self-report instrument used to assess satisfaction with health services and it is used to assess participant satisfaction with the treatment. Scores range from 8 - 32. Higher scores are associated with higher satisfaction.
at 10 weeks
Modifications of body mass index.
Time Frame: Change from baseline to post-treatment, to 6 months and at 12 months follow-up
modification of the body mass index (BMI). Weight in Kg. and Height ill be combined to report BMI in kg/m^2.
Change from baseline to post-treatment, to 6 months and at 12 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Miguel A. Galán Martín, Castilla-León Health Service

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2017

Primary Completion (ANTICIPATED)

November 30, 2020

Study Completion (ANTICIPATED)

December 30, 2020

Study Registration Dates

First Submitted

August 24, 2018

First Submitted That Met QC Criteria

August 29, 2018

First Posted (ACTUAL)

August 31, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 21, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • GRS 1396/A/16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Clinical Trials on Health Education

3
Subscribe